患者报告的亚托匹性皮肤炎和慢性疹的结果测量在临床实践中未得到充分利用
Ivan Cherrez-Ojeda1, Jean Bousquet2, Ana Giménez-Arnau3
1Universidad Espiritu Santo, Samborondon, Ecuador; Respiralab Research Group, Guayaquil, Ecuador.
The journal of allergy and clinical immunology. In practice
|April 11, 2024
概括
患者报告的结果措施 (PROMs) 尽管有好处,但在阿托皮性皮肤炎和慢性疹治疗中仍未充分利用. 时间限制等障碍阻碍了采用,需要改进实施策略.
科学领域:
- 皮肤病学和过敏学
- 临床研究方法论 临床研究方法论
- 患者报告的结果
背景情况:
- 患者报告的结果测量 (PROM) 对于监测阿托皮性皮肤炎 (AD) 和慢性疹 (CU) 是至关重要的.
- 当前的临床实践表明,在PROM利用方面,存在未得到满足的需求和知识差距.
- PROMs补充了医生评估,并指导治疗决策.
研究的目的:
- 调查PROMs对AD和CU的全球现实应用.
- 探索这些PROMs使用的网络和临床环境.
- 确定影响PROM采用和感知障碍的因素.
主要方法:
- 一项针对73个国家的2534名过敏和皮肤病专业中心医生的全球调查.
- 一个由53项组成的调查问卷评估了用于AD和CU的PROM的使用情况.
- 数据分析的重点是意识,使用率和相关的医生特征.
主要成果:
- 对PROMs的认识为51.6% (1308/2,534名医生).
- 对AD和CU的实际使用PROM分别为14%和15%,许多人不经常使用它们.
- PROM使用的关键驱动因素包括监测疾病控制;主要障碍是时间限制和感知到的患者不喜欢.
结论:
- 尽管有好处,但PROM在常规临床实践中对AD和CU的实施是不理想的.
- 医生认为,在持续使用PROM方面存在重大障碍.
- 加强PROM的采用需要解决已识别的障碍,并与国家/国际标准保持一致.
更多相关视频
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
428
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
428
Methods of Documentation II: POMR
944
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
944


